8 employees
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
2019
$1.5M
from 4 investors over 4 rounds
RealSeq Biosciences raised $1.5M on July 28, 2023
Investors: Angel Star Ventures, - and Tech Coast Angels Los Angeles
RealSeq Biosciences raised undisclosed on July 6, 2022
Investors: BioTools Innovator